Exisulind and Intermittent Androgen Suppression (ADT) in Biochemical Relapsed Prostate Cancer
Clinical trial NCT00283803 · COMPLETED
Trial details
- NCT number
- NCT00283803
- Sponsor
- University of Washington
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-03-12
- Primary completion
- 2011-10-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.